PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
IDR 169.0
(0.59%)
IDR 169.0
(0.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 75.88 Billion IDR | 157.17% |
| 2022 | 29.5 Billion IDR | -26.57% |
| 2021 | 40.18 Billion IDR | 19.92% |
| 2020 | 33.5 Billion IDR | 162.55% |
| 2019 | 12.76 Billion IDR | 14.23% |
| 2018 | 11.17 Billion IDR | 112.02% |
| 2017 | 5.26 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 93.93 Billion IDR | 1.56% |
| 2024 Q1 | 92.49 Billion IDR | 21.89% |
| 2023 Q1 | 38.98 Billion IDR | 32.1% |
| 2023 Q2 | 39.76 Billion IDR | 2.01% |
| 2023 FY | 75.88 Billion IDR | 157.17% |
| 2023 Q4 | 75.88 Billion IDR | 40.78% |
| 2023 Q3 | 53.9 Billion IDR | 35.55% |
| 2022 FY | 29.5 Billion IDR | -26.57% |
| 2022 Q4 | 29.5 Billion IDR | 17.16% |
| 2022 Q3 | 25.18 Billion IDR | 10.07% |
| 2022 Q2 | 22.88 Billion IDR | -42.43% |
| 2022 Q1 | 39.74 Billion IDR | -1.09% |
| 2021 Q1 | 32.44 Billion IDR | -3.18% |
| 2021 FY | 40.18 Billion IDR | 19.92% |
| 2021 Q3 | 44.78 Billion IDR | 33.1% |
| 2021 Q4 | 40.18 Billion IDR | -10.28% |
| 2021 Q2 | 33.65 Billion IDR | 3.72% |
| 2020 Q1 | - IDR | -100.0% |
| 2020 FY | 33.5 Billion IDR | 162.55% |
| 2020 Q4 | 33.5 Billion IDR | 0.0% |
| 2020 Q2 | 19.99 Billion IDR | 0.0% |
| 2019 Q4 | 12.76 Billion IDR | 0.0% |
| 2019 FY | 12.76 Billion IDR | 14.23% |
| 2019 Q3 | 12.76 Billion IDR | 0.0% |
| 2018 FY | 11.17 Billion IDR | 112.02% |
| 2017 FY | 5.26 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Prodia Widyahusada Tbk | 347.44 Billion IDR | 78.159% |